Navigation Links
New molecule discovered in fight against allergy
Date:2/15/2012

Scientists at The University of Nottingham have discovered a new molecule that could offer the hope of new treatments for people allergic to the house dust mite.

The team of immunologists led by Dr Amir Ghaem-Maghami and Professor Farouk Shakib in the University's School of Molecular Medical Sciences have identified the molecule DC-SIGN which appears to play a role in damping down the body's allergic response to the house dust mite .

The molecule can be found on the surface of the immune cells which play a key role in the recognition of a major allergen from house dust mites called Der p 1, a leading cause of asthma in northern Europe. The recognition of the allergen by the immune system is thought to lead to on-going sensitisation and the development of allergic symptoms.

The discovery furthers our understanding of how the body's immune system identifies and reacts to allergens, which could ultimately pave the way for developing new therapies or treatments for preventing allergies.

It's especially good news for the millions of people with asthma whose condition is worsened by their allergy to house dust mite and other environmental allergens. House dust mite droppings contain a whole raft of allergens that trigger a reaction when they become airborne and are inhaled.

Dr Amir Ghaem-Maghami said: "There has been a sharp increase in the prevalence of allergies over the past few decades and allergic asthma among children has reached epidemic proportions in many industrialised countries, including the UK. Despite improvements in patient care, mortality and morbidity of allergic asthma has remained high, and most therapies target symptoms rather than curing the condition.

"Many people with asthma are highly sensitive to airborne allergens such as those from house dust mite in fact, many studies have shown that up to 80 per cent of people with asthma are allergic to house dust mite.

"A better understanding of how the interaction between allergens and the immune system triggers allergy is vital if we are to develop more effective and efficient treatments for this debilitating condition."

Allergy is a disorder caused by the body's immune system reacting to harmless substances found in the environment, known as allergens. Believing itself under attack, the immune system produces an antibody called IgE, which eventually leads to the release of further chemicals (including histamine) by certain immune cells, which together cause an inflammatory response and the classic symptoms of allergy itchy eyes, sneezing, runny nose and wheezing.

The Nottingham work, published this week in the Journal of Biological Chemistry, has focused on the role of DC-SIGN, a receptor found on the surface of antigen presenting cells. These cells are among the first cells in the immune system that come into contact with allergens.

The team found that DC-SIGN binds to major allergen from house dust mite (Der p 1) and dogs (Can f 1) and seems to play a regulatory role in the allergic response to house dust mite allergens. The binding of allergen to DC-SIGN on antigen presenting cells seems to promote a mechanism that could dampen harmful immune responses to allergens.

This is opposite to the role of another allergen reception the mannose receptor that has previously been identified by the Nottingham group.

The discovery shows that DC-SIGN could potentially play a beneficial role in regulating immune responses to environmental allergens.


'/>"/>
Contact: Emma Thorne
emma.thorne@nottingham.ac.uk
44-011-595-15793
University of Nottingham
Source:Eurekalert

Related medicine news :

1. IU research team discovers TB disease mechanism and molecule to block it
2. Tiny molecules may tell big story about cardiovascular disease risk
3. New Cancer-Fighting Strategy Focuses On Signaling Molecules
4. Small molecule with high impact
5. Sigma-Aldrich Reaches Agreement to Sell Pfizers Bioactive Small Molecule Compounds
6. Inflammation Molecule May Determine Fat Levels
7. Exploring the Davids and Goliaths of therapeutic molecules
8. ACS Webinar focuses on drug discovery process for small molecule therapeutics
9. Fit People Release More Fat-Burning Molecules During Exercise
10. NIH-supported finding on cocaine addiction: Tiny molecule, big promise
11. MicroRNA molecule increases number of blood stem cells, may help improve cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Toronto, Ontario (PRWEB) , ... February 05, 2016 , ... ... the Scarborough General Hospital Burn Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned ... the Scarborough Hospital. He successfully completed his first three-year term as chief and began ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , official ... NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in ... from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are ...
(Date:2/5/2016)... Pass, OR (PRWEB) , ... February 05, 2016 , ... ... with modern technology, such water may be safer than regular municipal or well water. ... advocate and radio host Sharon Kleyne, could go a long way toward increasing public ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today ... for and donate to Give To Cure’s campaign that is crowdfunding clinical trials to ... make and share payments through a smart device. In 2015 alone, Venmo processed $7.5 ...
(Date:2/5/2016)... WA (PRWEB) , ... February 05, 2016 , ... ... firm, ranked #3 in the 2015 Best in KLAS: Software & Services for ... The annual Best in KLAS report independently ranks vendor performance by healthcare executives, ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... 2016 Aethlon Medical, Inc. (Nasdaq: AEMD ), ... will be presenting at Source Capital Group,s 2016 Disruptive Growth ... at 2:15 p.m. ET on Wednesday, February 10, 2016.  ... taking place at 3:15 p.m. ET. http://www.aethlonmedical.com .  ... after the conclusion of the live event. The panel discussion ...
(Date:2/5/2016)... York , February 5, 2016 ... Transparency Market Research report states that the global active ... 2014 and is predicted to reach US$185.9 bn by ... of 6.50% from 2014 to 2020. The title of ... Chemical/Biological, Captive/Contract Manufactured, by Geography, and by Therapeutic Area) ...
(Date:2/5/2016)... Ind. , Feb. 5, 2016  Zimmer Biomet ... pricing of the previously announced underwritten secondary offering of ... its stockholders, consisting of affiliates of Blackstone and Goldman ... at an initial price of $96.45 per share. The ... the offering.  Neither Zimmer Biomet nor any of its ...
Breaking Medicine Technology: